Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Adelphi Values
PCR55 QUALITY OF LIFE IN PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER: AN IRONMAN REGISTRY ANALYSIS
1Amgen, Thousand Oaks, CA, USA 2Adelphi Values, Bollington, United Kingdom 3Amgen Inc, Thousand Oaks, CA, USA 4Prostate Cancer Clinical Trials Consortium, New York, NY, USA 5Duke Cancer Institute, Durham, NC, USA 6Convergent Therapeutics, Cambridge, MA, USA 7Harvard T.H. Chan School of Public Health, Boston, MA, USA 8Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain 9BC Cancer - Vancouver Centre, University of British Columbia, Vancouver, BC, Canada 10Guy's and St Thomas' NHS...
Understanding the Patient Experience of Advanced Parkinson’s Disease: Qualitative Research with Patients and Expert Clinicians to Identify Symptoms and Associated Health-Related Quality of Life Impacts | Neurology and Therapy
Abstract Parkinson’s disease (PD) is a progressive neurodegenerative condition, characterized by motor symptoms (MS) and non-motor symptoms (NMS). Currently, there is no global definition of advanced PD, but those in advanced stages experience diverse and severe symptomatology, and significant impacts to their health-related quality of life (HRQoL).
Content Validity and Psychometric Evaluation of the Crohn’s Symptom Severity (CSS) Questionnaire in Patients with Moderately to Severely Active Crohn’s Disease | Advances in Therapy
Abstract Individuals living with Crohn’s disease (CD) experience burdensome symptoms. As such, it is important to measure CD symptom severity in clinical research. The goal of this study was to evaluate the content validity, psychometric performance, and score interpretability of a new patient-reported instrument, the Crohn’s Symptom Severity (CSS) questionnaire, among adolescents and adults with moderately to severely active CD.
comparative evaluation of the measurement properties of three histological indices of mucosal healing in ulcerative colitis: Geboes Score, Robarts Histopathology Index, and Nancy Index
When you visit web sites, they may store or retrieve data in your web browser. This storage is often necessary for basic functionality of the web site or the storage may be used for the purposes of marketing, analytics, and personalization of the web site such as storing your preferences.
Experience of switching from a daily to a less frequent administration of injection treatments
Data extraction and analysis A total of 13 publications were included in the final analysis (four from the primary search, two from the first additional search, and seven from the second additional search), summarizing data across five therapeutic areas, clinical trial designs, and injection regimens (Table 2). Initial targeted search: Patient experience of daily and weekly injection regimens in GHD.
A novel patient-reported outcomes instrument assessing the side effects of peanut oral immunotherapy
Abstract Background Patients treated with peanut oral immunotherapy (OIT) may experience adverse reactions, particularly during up-dosing. Objective To develop the Side-effects of Peanut Oral Immunotherapy Diary (SEPOD), an electronic questionnaire assessing the daily side-effects of peanut OIT in clinical trials. Methods Content and design of the SEPOD were informed by empirical literature review and meetings with 3 allergy/immunology experts.
Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis
Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis Online download statistics by month: Online download statistics by month: February 2020 to February 2020 AbstractFullPdf Feb 2020 496 494 276 Total 496 494 276 Read the full text or download the PDF: Log in using your username and password
Cost-Effectiveness Analysis of a HMGA2 Prognostic Test for Acute Myeloid Leukemia in a Canadian Setting
Key Points for Decision Makers 1 Introduction Acute myeloid leukemia (AML) is the fourth most common blood cancer in Canada [1]. In 2013, 1315 new cases of AML were diagnosed in Canada, approximately 3.8 cases per 100,000 people [1].
Evaluation of health-related quality of life and symptoms in patients with advanced non-squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 057
Publication HistoryPublished online: August 10, 2018Accepted: May 13, 2018; Received in revised form: May 7, 2018; Received: January 30, 2018;
442O Overall health status (HS) in patients (pts) with advanced (adv) non-squamous (NSQ) NSCLC treated with nivolumab (nivo) or docetaxel (doc) in CheckMate 057
Background: The CheckMate 057 randomized, open-label, phase III study evaluated the efficacy and safety of nivo vs doc in previously-treated pts with adv NSQ NSCLC. Overall survival was significantly improved with nivo vs doc, as were symptoms as assessed by the Lung Cancer Symptom Scale. Here we report the impact of nivo vs doc on overall pt-reported HS.
Web-Based Budget Impact And Pricing Scenarios Planning Model: Example From The United Kingdom
Develop a generic modelling approach to estimate and visualize optimal pricing levels of various drug classes in the UK. Present economic model as interactive web-based app and develop tool to inform regional healthcare budgeting and decision making.
Overall Survival, Health-Related Quality of Life, and Healthcare Resource Use: Independent Analyses from Checkmate 025, A Phase Iii Study of Nivolumab Versus Everolimus in Patients with Advanced or Metastatic Clear-Cell Renal Cell Carcinoma - Value in Hea
In CheckMate 025 (NCT01668784), nivolumab was evaluated for changes in OS, HRQoL, and HCRU versus everolimus in mRCC patients who had received prior anti-angiogenic therapy. Data revealed that significantly longer OS was achieved with nivolumab (25 vs 19.6 months; hazard ratio: 0.73, P=0.002) versus everolimus, with fewer patients having grade 3/4 drug-related adverse events (18.7%) compared with everolimus (36.5%).
The Economic Burden of Pediatric Asthma in the United States: Literature Review of Current Evidence
Journal List Springer Open Choice PMC6386052 Richard Perry,1 George Braileanu,1 Thomas Palmer,1 and Paul Stevens2 Richard Perry 1Adelphi Values, Manchester, UK George Braileanu 1Adelphi Values, Manchester, UK Thomas Palmer 1Adelphi Values, Manchester, UK Paul Stevens 2OMRON Healthcare Europe B.V., Hoofddorp, The Netherlands Author information Copyright and License information Disclaimer Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial...
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Adelphi
Contact Adelphi, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack